Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
66.92 EUR | -1.36% | -1.11% | +97.06% |
Apr. 11 | Health Care Slips on Risk Bias -- Health Care Roundup | DJ |
Apr. 11 | Trending : Novartis Begins Tender Offer for MorphoSys Shares | DJ |
Sales 2024 * | 252M 270M | Sales 2025 * | 325M 348M | Capitalization | 2.56B 2.74B |
---|---|---|---|---|---|
Net income 2024 * | -182M -195M | Net income 2025 * | -115M -123M | EV / Sales 2024 * | 9.74 x |
Net cash position 2024 * | 106M 114M | Net cash position 2025 * | 241M 258M | EV / Sales 2025 * | 7.12 x |
P/E ratio 2024 * |
-16
x | P/E ratio 2025 * |
-32.9
x | Employees | 524 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.59% |
Latest transcript on MorphoSys AG
1 day | -1.25% | ||
1 week | -1.11% | ||
Current month | -0.30% | ||
1 month | -0.37% | ||
3 months | +70.79% | ||
6 months | +124.46% | ||
Current year | +97.06% |
Managers | Title | Age | Since |
---|---|---|---|
Jean-Paul Kress
CEO | Chief Executive Officer | 59 | 19-08-31 |
Lucinda Crabtree
DFI | Director of Finance/CFO | 45 | 23-08-06 |
Luisa Ciccarelli
CTO | Chief Tech/Sci/R&D Officer | - | 21-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Brosnan
BRD | Director/Board Member | 69 | 18-05-16 |
Director/Board Member | 67 | 18-05-16 | |
Marc Cluzel
CHM | Chairman | 69 | 12-05-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.44% | 125 M€ | -.--% | ||
0.80% | 17 M€ | -.--% | - | |
0.11% | 2 M€ | -.--% | ||
0.02% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 67 | -1.25% | 287 128 |
24-04-26 | 67.85 | +0.15% | 39,191 |
24-04-25 | 67.75 | +0.07% | 56,527 |
24-04-24 | 67.7 | -0.07% | 63,222 |
24-04-23 | 67.75 | 0.00% | 55,900 |
Delayed Quote Xetra, April 29, 2024 at 03:45 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+97.06% | 2.73B | |
+1.51% | 42.75B | |
+49.05% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- MOR Stock